127 related articles for article (PubMed ID: 36183961)
1. Gene expression responses reflecting 5-FU-induced toxicity: Comparison between patient colon tissue and 3D human colon organoids.
Rodrigues D; van Kampen R; van Bodegraven AA; Kleinjans JCS; Jennen DGJ; de Kok TM
Toxicol Lett; 2022 Dec; 371():17-24. PubMed ID: 36183961
[TBL] [Abstract][Full Text] [Related]
2. New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids.
Rodrigues D; de Souza T; Coyle L; Di Piazza M; Herpers B; Ferreira S; Zhang M; Vappiani J; Sévin DC; Gabor A; Lynch A; Chung SW; Saez-Rodriguez J; Jennen DGJ; Kleinjans JCS; de Kok TM
Arch Toxicol; 2021 Aug; 95(8):2691-2718. PubMed ID: 34151400
[TBL] [Abstract][Full Text] [Related]
3. Unravelling Mechanisms of Doxorubicin-Induced Toxicity in 3D Human Intestinal Organoids.
Rodrigues D; Coyle L; Füzi B; Ferreira S; Jo H; Herpers B; Chung SW; Fisher C; Kleinjans JCS; Jennen D; de Kok TM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163210
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. A Transcriptomic Approach to Elucidate the Mechanisms of Gefitinib-Induced Toxicity in Healthy Human Intestinal Organoids.
Rodrigues D; Herpers B; Ferreira S; Jo H; Fisher C; Coyle L; Chung SW; Kleinjans JCS; Jennen DGJ; de Kok TM
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216325
[TBL] [Abstract][Full Text] [Related]
6. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.
Pandor A; Eggington S; Paisley S; Tappenden P; Sutcliffe P
Health Technol Assess; 2006 Nov; 10(41):iii-iv, xi-xiv, 1-185. PubMed ID: 17049138
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
8. IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients.
Spagnardi M; Paredes J; Zabaleta J; Garai J; Reyes T; Martello LA; Williams JL
Front Oncol; 2022; 12():1010380. PubMed ID: 36531053
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome-wide
Devall MAM; Drew DA; Dampier CH; Plummer SJ; Eaton S; Bryant J; Díez-Obrero V; Mo J; Kedrin D; Zerjav DC; Takacsi-Nagy O; Jennelle LT; Ali MW; Yilmaz ÖH; Moreno V; Powell SM; Chan AT; Peters U; Casey G
Cancer Prev Res (Phila); 2021 Dec; 14(12):1089-1100. PubMed ID: 34389629
[TBL] [Abstract][Full Text] [Related]
10. Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.
Chen L; Tian B; Liu W; Liang H; You Y; Liu W
Front Oncol; 2022; 12():855674. PubMed ID: 35425715
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.
Twelves C; Boyer M; Findlay M; Cassidy J; Weitzel C; Barker C; Osterwalder B; Jamieson C; Hieke K;
Eur J Cancer; 2001 Mar; 37(5):597-604. PubMed ID: 11290435
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation analysis of normal colon organoids from familial adenomatous polyposis patients reveals novel insight into colon cancer development.
Devall MA; Eaton S; Ali MW; Dampier CH; Weisenberger D; Powell SM; Li L; Casey G
Clin Epigenetics; 2022 Aug; 14(1):104. PubMed ID: 35999641
[TBL] [Abstract][Full Text] [Related]
13. Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting.
Di Costanzo F; Ravasio R; Sobrero A; Bertetto O; Vinante O; Luppi G; Labianca R; Amadori D; Barone C; Carlo Merlano M; Longo F; Mansueto G; Antonuzzo L; Gasperoni S
Clin Drug Investig; 2008; 28(10):645-55. PubMed ID: 18783303
[TBL] [Abstract][Full Text] [Related]
14. Toxicity and efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: A challenge or a dilemma?
Shahrokni A; Rajebi MR; Saif MW
Clin Colorectal Cancer; 2009 Oct; 8(4):231-4. PubMed ID: 19822515
[TBL] [Abstract][Full Text] [Related]
15. Use of capecitabine in management of early colon cancer.
Hameed H; Cassidy J
Cancer Manag Res; 2011; 3():295-9. PubMed ID: 21931503
[TBL] [Abstract][Full Text] [Related]
16. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.
Hennig IM; Naik JD; Brown S; Szubert A; Anthoney DA; Jackson DP; Melcher AM; Crawford SM; Bradley C; Brown JM; Seymour MT
J Clin Oncol; 2008 Jul; 26(20):3411-7. PubMed ID: 18612156
[TBL] [Abstract][Full Text] [Related]
17. Mouse organoids as an in vitro tool to study the in vivo intestinal response to cytotoxicants.
Jardi F; Kelly C; Teague C; Fowler-Williams H; Sevin DC; Rodrigues D; Jo H; Ferreira S; Herpers B; Van Heerden M; de Kok T; Pin C; Lynch A; Duckworth CA; De Jonghe S; Lammens L; Pritchard DM
Arch Toxicol; 2023 Jan; 97(1):235-254. PubMed ID: 36203040
[TBL] [Abstract][Full Text] [Related]
18. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice.
Zhang P; Lai ZL; Chen HF; Zhang M; Wang A; Jia T; Sun WQ; Zhu XM; Chen XF; Zhao Z; Zhang J
J Exp Clin Cancer Res; 2017 Dec; 36(1):190. PubMed ID: 29273065
[TBL] [Abstract][Full Text] [Related]
19. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
[TBL] [Abstract][Full Text] [Related]
20. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
